front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |review

Stages in the natural history of disease and lead time of screening

Lead time is the amount of time gained by earlier detection of a cancer by screening than by later detection with the appearance of symptoms. This can be seen in the Figure above. If this lead time is not associated with a decrease in mortality, then lead time bias is present.